You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Cyanate-induced cataracts in patients with sickle-cell hemoglobinopathies
D. H. Nicholson, D. R. Harkness, W. E. Benson and C. M. Peterson
Two young patients developed bilateral posterior subcapsular cataracts
while receiving oral sodium cyanate for treatment of sickle cell
hemoglobinopathy. In one of the patients, lens opacities regressed
spontaneously after cyanate therapy was discontinued.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
The Challenge of Painful Crisis in Sickle Cell Disease
Nagel JAMA 2001;286:2152-2153. FULL TEXT
